FDA Inspection
Almirall Hermal GmbHAlmirall Hermal GmbH – FDA Inspection, Apr 13, 2012
Record Details
This FDA Inspection record concerns Almirall Hermal GmbH, with an inspection on April 13, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Almirall Hermal GmbH
- Inspection Date
- April 13, 2012
- Product Type
- Drugs
View Company Profile
ID · c4d61820-f95c-4d3e-850c-78da5ef5c6c3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 779008
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.198(a)Procedures to be written and followed
- 21 CFR 211.111Establishment of time limitations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Almirall Hermal GmbH
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 6, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 29, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 26, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Almirall Hermal GmbH
- FDA Inspection 1270072 - 2021-05-06
- FDA Inspection 1086417 - 2019-03-29
- FDA Inspection 898000 - 2014-09-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.